Hims & Hers Health Today HIMS Hims & Hers Health $42.09 -22.13 (-34.46%) 52-Week Range $13.47 ▼ $72.98 P/E Ratio 61.00 Price Target $38.00 Add to Watchlist It's not often that investors come across the kind of companies that can yield a multi-bagger investment over the years. Still, today, there is one name that possesses all the right components (and timing) to make it a suitable investment for those seeking to compound their wealth in the coming years. This company is popular among value investors and in ...

Market Reaction - US stock futures are set to extend gains, with S&P 500 futures up 0.7%, Nasdaq futures gaining almost 1%, and Dow Jones futures up 0.6% following a ceasefire agreement between Israel and Iran [1] - The three major US stock indexes rallied around 0.9% the previous day after Iran launched missiles at a US air base in Qatar, which resulted in no casualties [2] Oil and Commodity Prices - Oil prices plunged significantly, with WTI falling nearly 13% from $74 to $64.48 per barrel after the ceasefire announcement [3] - Gold prices fell by 1.5%, and Treasury yields dropped to their lowest levels since early May [3] Company Performance - Shares of Exxon Mobil and Chevron decreased by 1.7% and 1.4% respectively in premarket trading [4] - Defence companies in Europe, including Lockheed Martin and Northrop Grumman, saw declines of 1.4% and 0.8% respectively in pre-market trading [6] Geopolitical Impact - Reports of Iran violating the ceasefire by firing two missiles were intercepted, leading to a small rebound in oil, gold, and bond yields [5] - Market analysts noted that the rapid decline in oil prices indicates that the market is treating the ceasefire agreement as a solid deal, but further violations could reverse this trend [7] Future Market Focus - With geopolitical risks expected to moderate, the market may shift focus to Q2 earnings season and US trade tariffs in the coming weeks [7] - Attention may also turn to the AI sector and volatility trends as summer approaches [8] Individual Company Updates - Nvidia stock rose by 0.9%, while CEO Jensen Huang is set to sell up to $865 million in shares by the end of 2025 [9] - Alphabet's stock increased by 1.4% despite potential tighter regulations from the UK's competition authority [10]

MISSISSAUGA, ON, June 24, 2025 /PRNewswire/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is pleased to announce that it has entered into a Letter of Intent ("LOI") with Rio Tinto Alcan Inc. ("RTA") to acquire the technology and related knowhow to manufacture its proprietary aluminum metal matrix composites ("MMC") and to facilitate the transfer of RTA's customers for the product. MMC is a ceramic particle-infused aluminum used in the automotive and rail industries for ligh ...

Google could be forced to change its search engine in the UK to give consumers more choice and control over how they interact with its search services, the competition regulator has warned.The Competition and Markets Authority (CMA) has laid out potential remedies Google may have to make, including allowing people to easily switch search engines through a legal requirement for so-called "choice screens". Also being considered is ensuring people can transfer their browser history to another provider, and a r ...

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQB:MMETF) (“Miata” or the “Company”) is pleased to announce that it has begun its planned drill test of the Puma Target. This follows the successful completion of the latest five holes drilled at the Golden Hand Target, for which assays are pending (see Miata news release dated June 19, 2025). Featuring a high-quality data set that showcases evidence of a potentially rich gold system, the Puma Targe ...

MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that it has entered into agreements with accredited investors in private placement transactions at $0.42 per share of common stock that resulted in gross proceeds of approximately $3.7 million, before deducting fees and expenses payable by the Company. Certain Company’s founders and directors participated ...

Deutsch العربية Français Important DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, a ...

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Sarepta Therapeutics, Inc. (NASDAQ: SRPT) for potential violations of the federal securities laws. If you invested in Sarepta, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action. Why is Sarepta being Investigated? Sarepta is a biopharmaceutical company focused on developing treatment ...

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential violations of the federal securities laws. If you invested in Hims & Hers, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/hims-hers-health-inc-class-action. Why is Hims & Hers being Investigated? Hims & Hers is a telehealth company that provides consumers access to ...

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Diversified Holdings and Compass Group Diversified Holdings, LLC (NYSE: CODI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Compass you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/compass-diversified-holdings. Investors ...